ARCHIVES

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

This article is from The Cancer Letter archive.

Vol. 12 No. 04 | January 24, 1986

Download PDF Visit The Full Archive

Related Articles

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Ludwig Cancer Research Donates $540 Million to Six Centers

January 10, 2014